Literature DB >> 2941285

Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue.

F D Daschner, M Westenfelder, A Dalhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2941285     DOI： 10.1007/bf02013992

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics of intravenously administered ciprofloxacin.

Authors:  R Wise; R M Lockley; M Webberly; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

2.  Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors:  G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

3.  Tissue distribution of ciprofloxacin following oral and intravenous administration.

Authors:  A Dalhoff; H U Eickenberg
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553
  3 in total
  11 in total

1.  Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.

Authors:  M Brunner; U Hollenstein; S Delacher; D Jäger; R Schmid; E Lackner; A Georgopoulos; H G Eichler; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Authors:  A Aminimanizani; P Beringer; R Jelliffe
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis.

Authors:  B Jacoberger; G Ubeaud; G Freys; T Pottecher; L Jung; J C Koffel
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.

Authors:  S M Smith; R H Eng; F Tecson-Tumang
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.

Authors:  P M Mertes; P Voiriot; C Dopff; H Scholl; M Clavey; J P Villemot; P Canton; J B Dureux
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

7.  Ciprofloxacin activity in cyst fluid from polycystic kidneys.

Authors:  L W Elzinga; T A Golper; A L Rashad; M E Carr; W M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 10.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.